Crystagen

Crystagen is one of the immune peptides in the Khavinson bioregulator family, the same Russian line as Epithalon, Pinealon and Vilon. The people who search for it are usually already reading about that family and want the one that's meant for the immune system as it ages.

The thymus, a small gland behind the breastbone, is where T cells (a type of white blood cell) are trained. It shrinks steadily from childhood, and by midlife it's a fraction of its early size. The Russian research group behind Crystagen built a whole career on the question of whether short peptides could help that aging immune system behave a little younger.

The uses people describe, most common first:

• Immune aging. Russian lab work reports that Crystagen and its relatives changed how immune cells grow and which genes they switch on, including heat-shock genes that help cells cope with stress.
• Getting through cold and flu season. Vendor and education pages describe running a course before winter, and some cite Russian reports of fewer respiratory infections in athletes. We couldn't find those reports in the main English-language research databases.
• A course alongside other bioregulators. People who already run Thymalin or Vilon sometimes add Crystagen, as reported in community discussion.

For a lot of women in midlife, the question underneath is why every cold now takes two weeks instead of four days. That's a reasonable thing to want help with. Whether Crystagen changes it in people hasn't been tested.

The evidence is thinner than for its better-known relatives. Thymalin, the extract Crystagen came from, has decades of Russian clinical use behind it. Crystagen itself is mostly cell work, where researchers added it to immune cells in a dish and measured growth and gene activity. Vendor pages quote bigger numbers, including immune markers improving in most of a group of older patients, and those trace to Russian reports we couldn't find in the main English-language research databases. That doesn't make them wrong, it means nobody outside the original group has checked them.

Thymalin, the older Russian product, is an extract of calf thymus that contains many peptides at once. Researchers took it apart, identified short fragments in it, and made those fragments synthetically. Crystagen is one of them, three amino acids long.

The idea behind the whole family is that very short peptides act as signals, something like a highlighter on a page of instructions, telling a cell which genes to read more often. For Crystagen, that claim rests on cell studies from one research group in St. Petersburg. There's no independent replication, and the claims on vendor pages are bigger than what we could verify.

Research vendors sell Crystagen as a freeze-dried powder, most often in 20 mg vials, which gets mixed with bacteriostatic water and injected under the skin. The Russian product is a capsule, typically 10 mg of peptide each, sold in boxes of 20 or 60.

The amounts differ a lot between the two. The injection pattern on peptide education pages is 200 mcg once a day for 10 days, and capsule labels give 10 to 20 mg a day for 10 to 20 days. Neither comes from a human dose-finding study, and the Crystagen dosage page sets out each pattern with its source, the mixing math and how long a vial lasts.

One detail changes how people buy it. A mixed vial keeps 28 days in the fridge, and a 10-day course at 200 mcg a day uses just 2 mg. So one 20 mg vial covers one course and most of it goes unused, which makes the per-vial price the real cost of a course. Unmixed powder keeps much longer, and vendors list fridge storage for it.

The vial and the capsule aren't swapped one for one. A capsule course can use 100 to 400 mg in total, against 2 mg for an injected course. Swallowed peptides are mostly broken down in the gut, which is the usual reason given for the much larger capsule amounts, though nobody has measured how much Crystagen gets through. If you change forms, use the amounts that go with that form.

You may also see Crystagen sold under its sequence, EDP or Glu-Asp-Pro, and it's the same peptide. Don't confuse it with Cortagen, a different Khavinson peptide that shares part of the name and part of the sequence but adds one more amino acid and was studied for the brain rather than the immune system. When a listing is ambiguous, the sequence on the lab report settles it.

There's very little to go on. No human safety trial has been published, the lab work doesn't describe toxicity, and vendor pages that call it well tolerated are reporting their own view. Nobody has studied it in pregnancy, while breastfeeding, or alongside prescription drugs.

People who inject it report mild redness or itching at the spot, the same as most small injected peptides. Because the point of Crystagen is to stir the immune system, anyone with an autoimmune condition, or on a medicine that suppresses immunity, is in the territory where it's least understood.

What nobody knows is how it behaves over years in people, or whether repeated courses add up to anything, good or bad. For a peptide meant to stir the immune system, that long-term picture is the gap that matters most, and for Crystagen it's blank.

With only a few vendors carrying it, the vial is the other thing to check. Look for a recent third-party lab report that confirms identity and purity before you compare per-milligram prices. For a three-amino-acid peptide, the report should show a single clean peak and a mass that matches Glu-Asp-Pro, and a vendor who can't show one for the batch you're buying is telling you something.

Crystagen has no approved medical use in the US. Vendors sell it as a research compound, and it isn't a controlled substance. In Russia it's sold as a capsule supplement, not as a prescription drug, so there's no approved label anywhere.

It reaches US buyers two ways. Research vendors sell the powder in vials, and some importers sell the Russian capsules. Neither has a pharmacy behind it, so a recent lab report tells you more than the name on the box. Buying capsules from overseas can also mean customs delays, so people who want a course before winter tend to order well ahead.

There's no Crystagen comparison page yet. The ones people weigh it against are close relatives. Thymalin is the whole thymus extract it was taken from, with the longest Russian clinical record. Vilon is the two-amino-acid immune peptide from the same lab. Thymosin alpha-1 is the immune peptide that has an approved drug behind it outside the US, and it has the most human data of the group. If the aging immune system is what brought you here, those two pages are the natural next reads, and Epithalon is the family member people reach for when the goal is longevity more broadly.

It's sold for research, and the big human trials haven't been run yet. You knew that, it's why you're reading this and not the label.